Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Jobic

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Circulation|November 13, 2012
Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter studyChristophe Tribouilloy, Dan Rusinaru, Sylvestre Maréchaux, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|January 4, 2011
Valvular heart disease associated with benfluorex therapy: results from the French multicentre registryFlorent Le Ven, Christophe Tribouilloy, Gilbert Habib, et al.
European Heart Journal. Cardiovascular Imaging|November 5, 2014
Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre studySylvestre Maréchaux, Dan Rusinaru, Yannick Jobic, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 6, 2019
In vivo validation of Dosemap software use in interventional cardiology with dosimetrics indicators and peak skin dose evaluationRomain Didier, David Bourhis, Chaker Oueslati, et al.
Archives of Cardiovascular Diseases|July 24, 2013
Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre studySylvestre Maréchaux, Antoine Jeu, Yannick Jobic, et al.
European Heart Journal|September 10, 2013
Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective studyChristophe Tribouilloy, Sylvestre Maréchaux, Yannick Jobic, et al.
Archives of Cardiovascular Diseases|December 22, 2019
Analysis of weather exposure 7 days before occurrence of ST-segment elevation myocardial infarctionRomain Didier, Florent Le Ven, Mehdi Ouchiha, et al.
Journal of the American College of Cardiology|April 12, 2008
Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter studyFranck Levy, Marcel Laurent, Jean Luc Monin, et al.
Journal of the American College of Cardiology|May 16, 2009
Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiographyChristophe Tribouilloy, Franck Lévy, Dan Rusinaru, et al.
International Journal of Cardiology|March 23, 2017
Head-to-head comparison of the diagnostic performance of coronary computed tomography angiography and dobutamine-stress echocardiography in the evaluation of acute chest pain with normal ECG findings and negative troponin tests: A prospective multicenter studyEric Durand, Fabrice Bauer, Nicolas Mansencal, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Circulation|November 13, 2012
Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter studyChristophe Tribouilloy, Dan Rusinaru, Sylvestre Maréchaux, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|January 4, 2011
Valvular heart disease associated with benfluorex therapy: results from the French multicentre registryFlorent Le Ven, Christophe Tribouilloy, Gilbert Habib, et al.
European Heart Journal. Cardiovascular Imaging|November 5, 2014
Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre studySylvestre Maréchaux, Dan Rusinaru, Yannick Jobic, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 6, 2019
In vivo validation of Dosemap software use in interventional cardiology with dosimetrics indicators and peak skin dose evaluationRomain Didier, David Bourhis, Chaker Oueslati, et al.
Archives of Cardiovascular Diseases|July 24, 2013
Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre studySylvestre Maréchaux, Antoine Jeu, Yannick Jobic, et al.
European Heart Journal|September 10, 2013
Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective studyChristophe Tribouilloy, Sylvestre Maréchaux, Yannick Jobic, et al.
Archives of Cardiovascular Diseases|December 22, 2019
Analysis of weather exposure 7 days before occurrence of ST-segment elevation myocardial infarctionRomain Didier, Florent Le Ven, Mehdi Ouchiha, et al.
Journal of the American College of Cardiology|April 12, 2008
Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter studyFranck Levy, Marcel Laurent, Jean Luc Monin, et al.
Journal of the American College of Cardiology|May 16, 2009
Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiographyChristophe Tribouilloy, Franck Lévy, Dan Rusinaru, et al.
International Journal of Cardiology|March 23, 2017
Head-to-head comparison of the diagnostic performance of coronary computed tomography angiography and dobutamine-stress echocardiography in the evaluation of acute chest pain with normal ECG findings and negative troponin tests: A prospective multicenter studyEric Durand, Fabrice Bauer, Nicolas Mansencal, et al.
Pageof 3